Myosin 9 anticorps (N-Term)
Aperçu rapide pour Myosin 9 anticorps (N-Term) (ABIN6243267)
Antigène
Voir toutes Myosin 9 (MYH9) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 134-165, N-Term
-
Homologie
- C, Rat
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This MYH9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 134-165 amino acids from the N-terminal region of human MYH9.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:1000. WB: 1:1000. FC: 1:10~50
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Date de péremption
- 6 months
-
-
- Myosin 9 (MYH9)
-
Autre désignation
- MYH9
-
Sujet
- This gene encodes a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain. The protein is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in MYH9 are the cause of non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness.
-
Poids moléculaire
- 226532
-
NCBI Accession
- NP_002464
-
UniProt
- P35579
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Integrin Complex
Antigène
-